Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha Underwood

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Addiction (Abingdon, England)|September 11, 2019
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17Christopher M Jones, Natasha Underwood, Wilson M Compton
Addiction (Abingdon, England)|January 12, 2020
Reducing negative consequences from use of methamphetamineWilson M Compton, Christopher M Jones, Natasha Underwood
Drug and Alcohol Dependence|May 23, 2022
County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019Brian Corry, Natasha Underwood, Laura J Cremer, et al.
Preventive Medicine Reports|January 3, 2022
Association between county-level sociodemographic characteristics and county-level differences in opioid dispensingLaura J Cremer, Natasha Underwood, Amber Robinson, et al.
Drug and Alcohol Dependence|September 11, 2021
The impact of community-level prevention strategies on high-dose opioid dispensing rates: 2014-2019Natasha Underwood, Laura Cremer, Jessica Duncan Cance, et al.
Substance Abuse|April 2, 2021
State-led opioid overdose prevention efforts: Challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS)Natasha Underwood, Cherie Rooks-Peck, Nida Ali, et al.
Journal of Substance Use and Addiction Treatment|February 8, 2024
Barriers to retention in medications for opioid use disorder treatment in real-world practiceVanessa I Villamil, Natasha Underwood, Laura J Cremer, et al.
Brain Communications|February 5, 2021
Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injuryEtienne Laverse, Tong Guo, Karl Zimmerman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Addiction (Abingdon, England)|September 11, 2019
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17Christopher M Jones, Natasha Underwood, Wilson M Compton
Addiction (Abingdon, England)|January 12, 2020
Reducing negative consequences from use of methamphetamineWilson M Compton, Christopher M Jones, Natasha Underwood
Drug and Alcohol Dependence|May 23, 2022
County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019Brian Corry, Natasha Underwood, Laura J Cremer, et al.
Preventive Medicine Reports|January 3, 2022
Association between county-level sociodemographic characteristics and county-level differences in opioid dispensingLaura J Cremer, Natasha Underwood, Amber Robinson, et al.
Drug and Alcohol Dependence|September 11, 2021
The impact of community-level prevention strategies on high-dose opioid dispensing rates: 2014-2019Natasha Underwood, Laura Cremer, Jessica Duncan Cance, et al.
Substance Abuse|April 2, 2021
State-led opioid overdose prevention efforts: Challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS)Natasha Underwood, Cherie Rooks-Peck, Nida Ali, et al.
Journal of Substance Use and Addiction Treatment|February 8, 2024
Barriers to retention in medications for opioid use disorder treatment in real-world practiceVanessa I Villamil, Natasha Underwood, Laura J Cremer, et al.
Brain Communications|February 5, 2021
Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injuryEtienne Laverse, Tong Guo, Karl Zimmerman, et al.
Pageof 1